News, Analysis & Insights on Nutrition, Supplements, and Health
Niacin was ‘surprisingly effective’ in prevention of eye disease
The addition of vitamin B3 to the drinking water of mice that are genetically predisposed to glaucoma led to the prevention of the disease in 93% of cases, say researchers.
Young, healthy men are more likely to actively avoid, rather than be attracted to, products with prominent health claims such as reduced-fat or high-fibre, according to new research in Spain.
Nutrition labels do not seem to be adapted to battling public health issues such as obesity, the French food safety agency ANSES has concluded – but this is because they should not be used alone, say campaigners.
Asian consumers are far more likely to be interested in healthy eating than those in the West, according to a new survey of attitudes to diet and nutrition.
Two job role changes have been announced at Natural Products NZ (NPNZ), the industry body representing the country’s natural products, functional foods, complementary medicines, and nutraceuticals industries.
ARCHIVE ARTICLE OF THE WEEK
The interest in stool transplants or faecal microbial transplants has gathered momentum in recent years giving rise to the concept of faecal biobanks.
The US Department of Justice has filed a proposed consent decree that permanently instructs Louisiana-based Pick and Pay, Inc./ Cili Minerals LLC to stop distributing misbranded and unapproved new drugs and misbranded and adulterated dietary supplements.
The use of probiotics on very low birth weight (VLBW) infants is associated with a reduced risk of necrotizing enterocolitis (NEC), late-onset sepsis, and mortality, but the effects on extremely low birth weight (ELBW) babies is inconclusive.
The bone broth category (shelf-stable and refrigerated) is pretty small in the scheme of things, but it’s growing rapidly, with US retail sales more than tripling to $19.7m in the 52 weeks to Jan 22,* fueled by a small but highly engaged set of health...
The price of GNC shares hit a 52-week low after the company announced disappointing year-end earnings.
If you want to play in the krill game, you have to go big, says Aker BioMarine CEO Matts Johansen. And after years of development and investment, Aker BioMarine is finally achieving the scale necessary to be reliably profitable.